The story of Viagra, and its developer copyright, presents a complex case study for investors. Originally a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of knock-off https://techonpage.com/story6879600/sildenafil-and-big-pharma-a-uncertain-investment